A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody-Drug Conjugates (ADCs).
Saved in:
| Title: | A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody-Drug Conjugates (ADCs). |
|---|---|
| Authors: | Miller ML; ImmunoGen, Inc., Waltham, Massachusetts., Shizuka M; ImmunoGen, Inc., Waltham, Massachusetts., Wilhelm A; ImmunoGen, Inc., Waltham, Massachusetts., Salomon P; ImmunoGen, Inc., Waltham, Massachusetts., Reid EE; ImmunoGen, Inc., Waltham, Massachusetts., Lanieri L; ImmunoGen, Inc., Waltham, Massachusetts., Sikka S; ImmunoGen, Inc., Waltham, Massachusetts., Maloney EK; ImmunoGen, Inc., Waltham, Massachusetts., Harvey L; ImmunoGen, Inc., Waltham, Massachusetts., Qiu Q; ImmunoGen, Inc., Waltham, Massachusetts., Archer KE; ImmunoGen, Inc., Waltham, Massachusetts., Bai C; ImmunoGen, Inc., Waltham, Massachusetts., Vitharana D; ImmunoGen, Inc., Waltham, Massachusetts., Harris L; ImmunoGen, Inc., Waltham, Massachusetts., Singh R; ImmunoGen, Inc., Waltham, Massachusetts., Ponte JF; ImmunoGen, Inc., Waltham, Massachusetts., Yoder NC; ImmunoGen, Inc., Waltham, Massachusetts., Kovtun Y; ImmunoGen, Inc., Waltham, Massachusetts., Lai KC; ImmunoGen, Inc., Waltham, Massachusetts., Ab O; ImmunoGen, Inc., Waltham, Massachusetts., Pinkas J; ImmunoGen, Inc., Waltham, Massachusetts., Keating TA; ImmunoGen, Inc., Waltham, Massachusetts., Chari RVJ; ImmunoGen, Inc., Waltham, Massachusetts. ravi.chari@immunogen.com. |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2018 Mar; Vol. 17 (3), pp. 650-660. Date of Electronic Publication: 2018 Feb 13. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29440292 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody-Drug Conjugates (ADCs). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Miller+ML%22">Miller ML</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Shizuka+M%22">Shizuka M</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Wilhelm+A%22">Wilhelm A</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Salomon+P%22">Salomon P</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Reid+EE%22">Reid EE</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lanieri+L%22">Lanieri L</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Sikka+S%22">Sikka S</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Maloney+EK%22">Maloney EK</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Harvey+L%22">Harvey L</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Qiu+Q%22">Qiu Q</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Archer+KE%22">Archer KE</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bai+C%22">Bai C</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Vitharana+D%22">Vitharana D</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Harris+L%22">Harris L</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Singh+R%22">Singh R</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ponte+JF%22">Ponte JF</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Yoder+NC%22">Yoder NC</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kovtun+Y%22">Kovtun Y</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lai+KC%22">Lai KC</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ab+O%22">Ab O</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Pinkas+J%22">Pinkas J</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Keating+TA%22">Keating TA</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Chari+RVJ%22">Chari RVJ</searchLink>; ImmunoGen, Inc., Waltham, Massachusetts. ravi.chari@immunogen.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2018 Mar; Vol. 17 (3), pp. 650-660. <i>Date of Electronic Publication: </i>2018 Feb 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29440292 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1535-7163.MCT-17-0940 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 650 Titles: – TitleFull: A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody-Drug Conjugates (ADCs). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Miller ML – PersonEntity: Name: NameFull: Shizuka M – PersonEntity: Name: NameFull: Wilhelm A – PersonEntity: Name: NameFull: Salomon P – PersonEntity: Name: NameFull: Reid EE – PersonEntity: Name: NameFull: Lanieri L – PersonEntity: Name: NameFull: Sikka S – PersonEntity: Name: NameFull: Maloney EK – PersonEntity: Name: NameFull: Harvey L – PersonEntity: Name: NameFull: Qiu Q – PersonEntity: Name: NameFull: Archer KE – PersonEntity: Name: NameFull: Bai C – PersonEntity: Name: NameFull: Vitharana D – PersonEntity: Name: NameFull: Harris L – PersonEntity: Name: NameFull: Singh R – PersonEntity: Name: NameFull: Ponte JF – PersonEntity: Name: NameFull: Yoder NC – PersonEntity: Name: NameFull: Kovtun Y – PersonEntity: Name: NameFull: Lai KC – PersonEntity: Name: NameFull: Ab O – PersonEntity: Name: NameFull: Pinkas J – PersonEntity: Name: NameFull: Keating TA – PersonEntity: Name: NameFull: Chari RVJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2018 Mar Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1538-8514 Numbering: – Type: volume Value: 17 – Type: issue Value: 3 Titles: – TitleFull: Molecular cancer therapeutics Type: main |
| ResultId | 1 |